Skip to main content

Table 2 Antibiotic susceptibility of S. maltophilia clinical isolates (n = 85)

From: Antibiotic resistance, biofilm formation, and biofilm-associated genes among Stenotrophomonas maltophilia clinical isolates

Antimicrobial agents

Antimicrobial susceptibility pattern, n (%)

Susceptible

Intermediate

Resistant

Imipenem

–

–

85 (100%)

Meropenem

–

–

85 (100%)

Doripenem

–

–

85 (100%)

Ceftazidime

24 (28.24%)

–

61 (75.72%)

Minocycline

85 (100%)

–

–

Levofloxacin

81 (95.29%)

–

4 (4.71%)

Sulfamethoxazole/trimethoprim

83 (97.65%)

–

2 (2.35%)